SCHEMBL8287097

SCHEMBL8287097

CC(=O)c1cccc(-c2ccc3c(=O)cc(Nc4ccccc4)n(-c4ccccc4)c3n2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APAF1 O14727 1/20 0.47
TDP2 O95551 1/20 0.47
NPC1 O15118 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 3/20 0.42
RAB9A P51151 3/20 0.42
POLB P06746 2/20 0.42
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM1A O60341 1/20 0.41
ATR Q13535 1/20 0.40
TP53 P04637 2/20 0.40
RXFP1 Q9HBX9 1/20 0.39
BRAF P15056 1/20 0.39
AURKA O14965 1/20 0.38
DAPK3 O43293 1/20 0.38
JAK2 O60674 1/20 0.38
MAP4K4 O95819 1/20 0.38
ABL1 P00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287125 0.91 APAF1 (0.39) APAF1TDP2NPC1MEN1KMT2A
SCHEMBL8287132 0.87 PDE11A (0.43) ALDH1A1GSK3BGAANPSR1PDE11A
SCHEMBL8287357 0.85 PDE11A (0.41) NPC1MEN1KMT2AMAPTRAB9A
SCHEMBL8287099 0.81 PDE11A (0.56) APAF1TDP2NPC1MEN1KMT2A
SCHEMBL8285307 0.81 ATR (0.42) APAF1TDP2NPC1MEN1KMT2A
SCHEMBL8287862 0.80 PDE11A (0.42) NPC1MEN1KMT2AMAPTRAB9A
SCHEMBL8287098 0.78 PDE11A (0.39) POLBALDH1A1SMN1; SMN2GSK3BGAA
SCHEMBL5872091 0.77 MAT2A (0.54) MEN1KMT2AALDH1A1SMN1; SMN2MAPK8
SCHEMBL8287860 0.75 LOXL3 (0.50) NPC1MEN1KMT2AMAPTPOLB
SCHEMBL8287383 0.75 PDE11A (0.41) NPC1MEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed